Listed

Boston Scientific Corp

BSXNYSECIK 885725HealthcareFiscal year ends Dec 31

Reports and events: 396 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Boston Scientific Corp, Reports and events
FiledFormWhat it isAccession number
2021-08-0616:36 ET10-QQuarterly reportPeriod 2021-06-300000885725-21-000036
2021-08-0216:31 ET8-K/A5.02 Departure or appointment of officers or directors0000885725-21-000032
2021-07-2706:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-21-000028
2021-06-2416:56 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885725-21-000025
2021-06-2416:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-21-000024
2021-05-1316:04 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-21-065917
2021-05-1116:49 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000885725-21-000016
2021-05-0617:02 ET10-QQuarterly reportPeriod 2021-03-310000885725-21-000014
2021-04-2806:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-21-000012
2021-03-2416:19 ETDEF 14AProxy statementPeriod 2021-05-060001047469-21-000709
2021-03-1116:41 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885725-21-000010
2021-03-0307:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-031097
2021-03-0116:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-029993
2021-02-2316:21 ET10-KAnnual reportPeriod 2020-12-310000885725-21-000008
2021-02-0306:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-21-000006
2021-01-2107:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-21-000004
2021-01-1206:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-21-000002
2020-12-1416:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-20-000053
2020-12-0106:37 ET8-K2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits0000885725-20-000051
2020-11-2416:17 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885725-20-000049
2020-11-1818:21 ET8-K2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits0000885725-20-000046
2020-11-0506:48 ET10-QQuarterly reportPeriod 2020-09-300000885725-20-000044
2020-10-2806:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-20-000041
2020-10-0516:11 ET8-K5.02 Departure or appointment of officers or directors0000885725-20-000039
2020-08-0520:31 ET10-QQuarterly reportPeriod 2020-06-300000885725-20-000036
2020-08-0320:04 ET8-K5.02 Departure or appointment of officers or directors0000885725-20-000034
2020-07-2910:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-20-000031
2020-06-0820:31 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000947871-20-000545
2020-05-2920:54 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000947871-20-000527
2020-05-2801:54 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0000947871-20-000519
2020-05-2201:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-065010
2020-05-1821:07 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0000947871-20-000487
2020-05-1500:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-061823
2020-05-1220:08 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000885725-20-000024
2020-05-0621:20 ET10-QQuarterly reportPeriod 2020-03-310000885725-20-000022
2020-04-2910:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-20-000019
2020-04-2120:26 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0000947871-20-000397
2020-04-1013:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-045409
2020-04-0210:40 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885725-20-000017
2020-03-3010:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-20-000014
2020-03-2520:30 ETDEF 14AProxy statementPeriod 2020-05-070001047469-20-001770
2020-02-2721:52 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0000947871-20-000156
2020-02-2521:58 ET10-KAnnual reportPeriod 2019-12-310000885725-20-000012
2020-02-0511:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-20-000009
2020-02-0511:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885725-20-000007
2020-01-1411:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000885725-20-000003
2019-12-1822:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000947871-19-000976
2019-12-0522:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0000947871-19-000894
2019-11-2614:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000947871-19-000866
2019-11-2021:03 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885725-19-000048

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.